SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-24-000919
Filing Date
2024-07-15
Accepted
2024-07-15 19:19:57
Documents
2
Period of Report
2024-07-11

Document Format Files

Seq Description Document Type Size
1 e663780_4-biomx.html 4  
1 e663780_4-biomx.xml 4 7042
2 e663780_ex99.htm EX-99 3665
  Complete submission text file 0001193805-24-000919.txt   13006
Mailing Address 345 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10010 2125511600
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (Reporting) CIK: 0001009258 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-38762 | Film No.: 241118335

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Reporting) CIK: 0001352546 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38762 | Film No.: 241118336

Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Issuer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)